688617.SHG APT Medical Inc
- Market cap
- CNY 39.9B
- P/E
- 38.8x
- P/B
- 11.59x
- ROE
- 32.2%
- Dividend yield
- 0.43%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 688617.SHG undervalued?
Graham numberThe Graham number of APT Medical Inc cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
APT Medical Inc fundamental analysis
No fundamental analysis for APT Medical Inc yet.
APT Medical Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About APT Medical Inc
APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagnostic products, therapeutic products, and accessories. The company also manufactu…
Full company profileAPT Medical Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
APT Medical Inc annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 153M | 242M | 404M | 479M | 829M | 1.22B | 1.65B | 2.07B | 2.58B | 3.14B |
| Gross Profit | 105M | 166M | 286M | 337M | 570M | 862M | 1.16B | 1.49B | 2.58B | 2.30B |
| Operating Income | 31.1M | 23.6M | 92.1M | 119M | 223M | 397M | 600M | 754M | 944M | 1.23B |
| EBITDA | 39.0M | 32.6M | 106M | 142M | 251M | 438M | 656M | 825M | 1.01B | 1.24B |
| Net Income | 34.5M | 21.5M | 82.6M | 111M | 208M | 358M | 534M | 673M | 821M | 1.09B |
| EPS | 0.33 | 0.20 | 0.78 | 1.06 | 1.51 | 2.52 | 3.77 | 4.77 | 5.82 | 7.71 |
| Balance Sheet | ||||||||||
| Total Assets | 253M | 326M | 561M | 589M | 2.01B | 2.23B | 2.57B | 2.98B | 3.66B | 4.02B |
| Total Liabilities | 38.3M | 55.1M | 215M | 139M | 222M | 435M | 611M | 426M | 477M | 606M |
| Shareholders' Equity | 214M | 270M | 350M | 460M | 1.78B | 1.76B | 1.91B | 2.52B | 3.09B | 3.39B |
| Cash & Short-term Investments | 79.4M | 90.8M | 73.5M | 120M | 1.22B | 1.13B | 1.34B | 1.08B | 1.51B | 1.29B |
| Total Debt | 1.00M | 10.5M | 138M | 39.1M | 46.6M | 52.6M | 89.9M | 11.3M | 19.4M | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | 12.9M | 18.6M | 54.9M | 148M | 181M | 367M | 689M | 743M | 975M | - |
| Capital Expenditure | 25.3M | 32.2M | 67.6M | 44.2M | 167M | 143M | 202M | 650M | 286M | 169M |
| Free Cash Flow | -12.4M | -13.6M | -12.7M | 104M | 14.0M | 224M | 487M | 93.1M | 690M | 1.10B |
| Ratios | ||||||||||
| ROE | 16.1% | 8.0% | 23.6% | 24.1% | 11.7% | 20.3% | 28.0% | 26.8% | 26.6% | 32.2% |
| ROA | 13.6% | 6.6% | 14.7% | 18.8% | 10.3% | 16.1% | 20.8% | 22.6% | 22.5% | 27.1% |
| Net Profit Margin | 22.5% | 8.9% | 20.4% | 23.1% | 25.1% | 29.4% | 32.4% | 32.6% | 31.8% | 34.7% |
| Debt to Equity | 0.00x | 0.04x | 0.39x | 0.08x | 0.03x | 0.03x | 0.05x | 0.00x | 0.01x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
APT Medical Inc dividends
- Dividend yield
- 0.43%
- Forward dividend
- 1.00 CNY
- Payout ratio
- 20.7%
- Ex-dividend date
- May 14, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 170M | 1.21 | 20.7% |
| 2024 | CNY 134M | 0.95 | 19.9% |
| 2023 | CNY 112M | 0.79 | 21.0% |
| 2022 | CNY 66.7M | 0.47 | 18.6% |
| 2021 | CNY 33.3M | 0.24 | 16.0% |
| 2020 | CNY 1.41M | 0.01 | 1.3% |
| 2019 | CNY 5.97M | 0.06 | 7.2% |
| 2018 | 268K | 0.00 | 1.2% |
| 2017 | 461K | 0.00 | 1.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.45:1 on Jun 19, 2025.
Who owns APT Medical Inc
- Insiders 48.96%
- Institutions 18.86%
- Public & others 32.19%
- Shares outstanding 142M
- Free float 73.5M
APT Medical Inc company profile
- Company name
- APT Medical Inc
- Ticker
- 688617.SHG
- ISIN
- CNE100004C45
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 3,118
- Fiscal year end
- December
- Address
- Building B, Tongfang Information Port, Shenzhen, China, 518000
- Phone
- 86 755 8359 1013
- Website
- aptmed.com
About APT Medical Inc
APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagnostic products, therapeutic products, and accessories. The company also manufactures and supplies EP and vascular intervention medical devices. In addition, it provides OEM and ODM services comprising project design and development, customization, and volume OEM; and customized products consisting of catheters, guidewires, and delivery systems, as well as nitinol products in cardiology, peripheral, neurology, and urology. APT Medical Inc. was founded in 2002 and is headquartered in Shenzhen, China.
APT Medical Inc management
9- Mr. Zhenghui ChengPresident, GM & Vice Chairman · born 1964
- Ms. Qi Han GuiFinancial Officer · born 1980
- Mr. Zhenhua DaiDeputy GM & Employee Representative Director · born 1968
- Mr. Yuchen QiuDeputy General Manager · born 1965
- Mr. Yonggui HanDeputy General Manager · born 1963
- Mr. Fangyuan LiuDeputy General Manager · born 1976
- Mr. Wei WangDeputy General Manager · born 1971
- Mr. Wang JinheDeputy General Manager · born 1974
- Ye Hui ChenAccounting Supervisor